Nexcella

Nexcella, a wholly-owned subsidiary of mmix Biopharma, is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cell therapies for oncology and other indications. Our N-GENIUS platform enables us to discover, develop, and manufacture cutting-edge cell therapies for patients in need.